IS7862A - Verkjalyf - Google Patents

Verkjalyf

Info

Publication number: IS7862A
Authority: IS; Iceland
Prior art keywords: painkillers
Prior art date: 2002-11-08

Application number

IS7862A

Other languages

English (en)

Inventor

Robert Milnes Coates Anthony

Original Assignee

Helperby Therapeutics Limited

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-11-08

Filing date

2005-05-24

Publication date

2005-05-24

2005-05-24 Application filed by Helperby Therapeutics Limited filed Critical Helperby Therapeutics Limited

2005-05-24 Publication of IS7862A publication Critical patent/IS7862A/is

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Pain & Pain Management (AREA)
Gastroenterology & Hepatology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Dermatology (AREA)
Genetics & Genomics (AREA)
Oncology (AREA)
Endocrinology (AREA)
Reproductive Health (AREA)
Pulmonology (AREA)
Microbiology (AREA)
Mycology (AREA)
Biotechnology (AREA)
Urology & Nephrology (AREA)
Molecular Biology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

IS7862A 2002-11-08 2005-05-24 Verkjalyf IS7862A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
GBGB0226105.5A GB0226105D0 (en)	2002-11-08	2002-11-08	Pain relief agents
PCT/GB2003/004774 WO2004041304A2 (en)	2002-11-08	2003-11-05	Pain relief agents

Publications (1)

Publication Number	Publication Date
IS7862A true IS7862A (is)	2005-05-24

Family

ID=9947469

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7862A IS7862A (is)	2002-11-08	2005-05-24	Verkjalyf

Country Status (17)

Country	Link
US (1)	US7744906B2 (is)
EP (1)	EP1562625A2 (is)
JP (1)	JP4607593B2 (is)
KR (1)	KR20050086465A (is)
CN (1)	CN1735427A (is)
AU (1)	AU2003279454B2 (is)
BR (1)	BR0316053A (is)
CA (1)	CA2503964A1 (is)
CO (1)	CO5640148A2 (is)
GB (2)	GB0226105D0 (is)
IS (1)	IS7862A (is)
MX (1)	MXPA05004973A (is)
NO (1)	NO20052216L (is)
NZ (1)	NZ539867A (is)
RU (1)	RU2005117635A (is)
WO (1)	WO2004041304A2 (is)
ZA (1)	ZA200503615B (is)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1715884B1 (en) *	2004-01-16	2012-03-07	CBIO Limited	Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
AU2005204979B2 (en) *	2004-01-16	2010-10-21	Cbio Limited	Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion
GB0803369D0 (en)	2008-02-25	2008-04-02	Helperby Therapeutics Ltd	Biological materials and uses thereof
GB201118201D0 (en) *	2011-10-21	2011-12-07	Helperby Therapeutics Ltd	Novel peptides
US9757395B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
US9757529B2 (en)	2012-12-20	2017-09-12	Otitopic Inc.	Dry powder inhaler and methods of use
CN105473133A (zh)	2013-04-30	2016-04-06	欧缇托匹克公司	干粉制剂及使用方法
GB201700557D0 (en)	2017-01-12	2017-03-01	Peptinnovate Ltd	Novel peptides
GB201700555D0 (en)	2017-01-12	2017-03-01	Peptinnovate Ltd	Method for the treatment of a relapsing-remitting condition
US12358957B2 (en)	2017-01-12	2025-07-15	Revolo Biotherapeutics Limited	Method for the acute treatment of atopic dermatitis and allergic skin hypersensitivity
WO2019059953A2 (en)	2017-09-22	2019-03-28	Otitopic Inc.	DRY POWDER COMPOSITIONS CONTAINING MAGNESIUM STEARATE
US10786456B2 (en)	2017-09-22	2020-09-29	Otitopic Inc.	Inhaled aspirin and magnesium to treat inflammation

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4440859A (en) *	1977-05-27	1984-04-03	The Regents Of The University Of California	Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms
US4704362A (en) *	1977-11-08	1987-11-03	Genentech, Inc.	Recombinant cloning vehicle microbial polypeptide expression
LU88258I2 (is) *	1978-12-22	1994-02-03
US4530901A (en) *	1980-01-08	1985-07-23	Biogen N.V.	Recombinant DNA molecules and their use in producing human interferon-like polypeptides
US4678751A (en) *	1981-09-25	1987-07-07	Genentech, Inc.	Hybrid human leukocyte interferons
US4766075A (en) *	1982-07-14	1988-08-23	Genentech, Inc.	Human tissue plasminogen activator
US4582800A (en) *	1982-07-12	1986-04-15	Hoffmann-La Roche Inc.	Novel vectors and method for controlling interferon expression
US4757006A (en) *	1983-10-28	1988-07-12	Genetics Institute, Inc.	Human factor VIII:C gene and recombinant methods for production
US4677063A (en) *	1985-05-02	1987-06-30	Cetus Corporation	Human tumor necrosis factor
US4810648A (en) *	1986-01-08	1989-03-07	Rhone Poulenc Agrochimie	Haloarylnitrile degrading gene, its use, and cells containing the gene
PT731811E (pt) *	1993-11-30	2005-04-29	Univ Queensland	Chaperonina 10
CA2176948C (en) *	1993-11-30	2007-05-15	Halle Morton	Chaperonin 10
IT1271074B (it) *	1994-11-21	1997-05-26	Italfarmaco Spa	Peptidi ad attivita' antiinfiammatoria
DE69735376T2 (de) *	1996-11-26	2006-12-14	Stressgen Biotechnologies Corp., Victoria	Fusionsproteine, die stressproteine beinhalten, zum hervorrufen einer immunantwort
JP2002508156A (ja)	1997-12-31	2002-03-19	ストレスジェンバイオテクノロジーズコーポレイション	Ｈｓｐ６０ファミリーのＳｔｒｅｐｔｏｃｏｃｃｕｓ熱ショックタンパク質
EP1049483A1 (en) *	1998-01-23	2000-11-08	National Jewish Medical and Research Center	Method for treating inflammatory diseases using heat shock proteins
IL126447A (en) *	1998-10-04	2004-09-27	Vascular Biogenics Ltd	An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
CN1367875A (zh) *	1999-07-08	2002-09-04	斯特思吉生物技术公司	活体外th1一样反应的诱导方法
GB0028122D0 (en)	2000-11-17	2001-01-03	St Georges Entpr Ltd	Method
GB0803369D0 (en)	2008-02-25	2008-04-02	Helperby Therapeutics Ltd	Biological materials and uses thereof

2002
- 2002-11-08 GB GBGB0226105.5A patent/GB0226105D0/en not_active Ceased
2003
- 2003-11-05 MX MXPA05004973A patent/MXPA05004973A/es unknown
- 2003-11-05 KR KR1020057008263A patent/KR20050086465A/ko not_active Ceased
- 2003-11-05 RU RU2005117635/15A patent/RU2005117635A/ru not_active Application Discontinuation
- 2003-11-05 BR BR0316053-0A patent/BR0316053A/pt not_active IP Right Cessation
- 2003-11-05 CA CA002503964A patent/CA2503964A1/en not_active Abandoned
- 2003-11-05 US US10/534,054 patent/US7744906B2/en not_active Expired - Fee Related
- 2003-11-05 WO PCT/GB2003/004774 patent/WO2004041304A2/en not_active Ceased
- 2003-11-05 EP EP03772402A patent/EP1562625A2/en not_active Withdrawn
- 2003-11-05 JP JP2004549345A patent/JP4607593B2/ja not_active Expired - Fee Related
- 2003-11-05 CN CNA2003801085628A patent/CN1735427A/zh active Pending
- 2003-11-05 GB GB0325782A patent/GB2391477B/en not_active Expired - Fee Related
- 2003-11-05 AU AU2003279454A patent/AU2003279454B2/en not_active Ceased
- 2003-11-05 NZ NZ539867A patent/NZ539867A/en not_active IP Right Cessation
2005
- 2005-05-05 ZA ZA200503615A patent/ZA200503615B/xx unknown
- 2005-05-09 NO NO20052216A patent/NO20052216L/no not_active Application Discontinuation
- 2005-05-24 IS IS7862A patent/IS7862A/is unknown
- 2005-06-03 CO CO05054339A patent/CO5640148A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
JP4607593B2 (ja)	2011-01-05
RU2005117635A (ru)	2006-01-20
AU2003279454A1 (en)	2004-06-07
WO2004041304A2 (en)	2004-05-21
CA2503964A1 (en)	2004-05-21
WO2004041304A3 (en)	2004-07-29
AU2003279454B2 (en)	2008-06-19
GB0325782D0 (en)	2003-12-10
GB2391477A (en)	2004-02-11
GB2391477B (en)	2004-12-22
NO20052216D0 (no)	2005-05-09
US7744906B2 (en)	2010-06-29
KR20050086465A (ko)	2005-08-30
ZA200503615B (en)	2007-02-28
EP1562625A2 (en)	2005-08-17
US20060252681A1 (en)	2006-11-09
NZ539867A (en)	2008-06-30
CO5640148A2 (es)	2006-05-31
MXPA05004973A (es)	2005-11-23
BR0316053A (pt)	2005-09-20
CN1735427A (zh)	2006-02-15
JP2006514001A (ja)	2006-04-27
NO20052216L (no)	2005-08-05
GB0226105D0 (en)	2002-12-18

Publication	Publication Date	Title
ATE457980T1 (de)	2010-03-15	Aryloxime
ATE534648T1 (de)	2011-12-15	C-6-modifizierte indazolylpyrrolotriazine
DE50305852D1 (de)	2007-01-11	Einspritzventil
DE50306589D1 (de)	2007-04-05	Wischblatt
ATE318817T1 (de)	2006-03-15	Aza-arylpiperazine
ATE427876T1 (de)	2009-04-15	Luftkissenboot
DE50212360D1 (de)	2008-07-24	Anfahrhilfesteuerungsvorrichtung
DE50212349D1 (de)	2008-07-17	Hirurgie
DE50301200D1 (de)	2005-10-20	Wischblatt
DE50305301D1 (de)	2006-11-16	Einspritzventil
ATE349458T1 (de)	2007-01-15	Etonogestrelester
ATA1572002A (de)	2003-06-15	Managementspleisskassette
NO20052216D0 (no)	2005-05-09	Smertestillende midler
DE50302660D1 (de)	2006-05-11	Stopfmachine
DE50301960D1 (de)	2006-01-26	Hydrolager
DE50301464D1 (de)	2005-12-01	Schraubensicherung
ATA4142004A (de)	2005-12-15	Trägerverbau
ATE469773T1 (de)	2010-06-15	Zugöse
DE50305973D1 (de)	2007-01-25	Auffangwanne
DE50307628D1 (de)	2007-08-16	Getraenkehalter
DE50303317D1 (de)	2006-06-14	Einschub-leistungsschalter
ATA19152002A (de)	2004-11-15	Hubkupplung
DE50209283D1 (de)	2007-03-08	Tropfbewässerungsrohr
ATE396192T1 (de)	2008-06-15	N-sulfonylaminothiazole
DE50303658D1 (de)	2006-07-20	Postgutmessvorrichtung